These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37908349)

  • 1. Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humans.
    Hanna SJ; Thayer TC; Robinson EJS; Vinh NN; Williams N; Landry LG; Andrews R; Siah QZ; Leete P; Wyatt R; McAteer MA; Nakayama M; Wong FS; Yang JHM; Tree TIM; Ludvigsson J; Dayan CM; Tatovic D
    Front Immunol; 2023; 14():1276255. PubMed ID: 37908349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.
    Tatovic D; McAteer MA; Barry J; Barrientos A; Rodríguez Terradillos K; Perera I; Kochba E; Levin Y; Dul M; Coulman SA; Birchall JC; von Ruhland C; Howell A; Stenson R; Alhadj Ali M; Luzio SD; Dunseath G; Cheung WY; Holland G; May K; Ingram JR; Chowdhury MMU; Wong FS; Casas R; Dayan C; Ludvigsson J
    Immunother Adv; 2022; 2(1):ltac002. PubMed ID: 35919496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes.
    Arikat F; Hanna SJ; Singh RK; Vilela L; Wong FS; Dayan CM; Coulman SA; Birchall JC
    J Control Release; 2020 Jun; 322():593-601. PubMed ID: 32087298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy.
    Dul M; Nikolic T; Stefanidou M; McAteer MA; Williams P; Mous J; Roep BO; Kochba E; Levin Y; Peakman M; Wong FS; Dayan CM; Tatovic D; Coulman SA; Birchall JC;
    Int J Pharm; 2019 May; 562():303-312. PubMed ID: 30910633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APC-targeted proinsulin expression inactivates insulin-specific memory CD8
    Reeves PL; Rudraraju R; Liu X; Wong FS; Hamilton-Williams EE; Steptoe RJ
    Immunol Cell Biol; 2017 Oct; 95(9):765-774. PubMed ID: 28611473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.
    Michels AW; Landry LG; McDaniel KA; Yu L; Campbell-Thompson M; Kwok WW; Jones KL; Gottlieb PA; Kappler JW; Tang Q; Roep BO; Atkinson MA; Mathews CE; Nakayama M
    Diabetes; 2017 Mar; 66(3):722-734. PubMed ID: 27920090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides.
    Singh RK; Malosse C; Davies J; Malissen B; Kochba E; Levin Y; Birchall JC; Coulman SA; Mous J; McAteer MA; Dayan CM; Henri S; Wong FS
    Nanomedicine; 2021 Feb; 32():102321. PubMed ID: 33184020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.
    Gliwiński M; Iwaszkiewicz-Grześ D; Wołoszyn-Durkiewicz A; Tarnowska M; Żalińska M; Hennig M; Zielińska H; Dukat-Mazurek A; Zielkowska-Dębska J; Zieliński M; Jaźwińska-Curyłło A; Owczuk R; Jarosz-Chobot P; Bossowski A; Szadkowska A; Młynarski W; Marek-Trzonkowska N; Moszkowska G; Siebert J; Myśliwiec M; Trzonkowski P
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32098895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.
    So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model.
    Gibson VB; Nikolic T; Pearce VQ; Demengeot J; Roep BO; Peakman M
    Clin Exp Immunol; 2015 Dec; 182(3):251-60. PubMed ID: 26206289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.
    Thrower SL; James L; Hall W; Green KM; Arif S; Allen JS; Van-Krinks C; Lozanoska-Ochser B; Marquesini L; Brown S; Wong FS; Dayan CM; Peakman M
    Clin Exp Immunol; 2009 Feb; 155(2):156-65. PubMed ID: 19040615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients.
    Nikolic T; Suwandi JS; Wesselius J; Laban S; Joosten AM; Sonneveld P; Mul D; Aanstoot HJ; Kaddis JS; Zwaginga JJ; Roep BO
    Front Immunol; 2022; 13():1054968. PubMed ID: 36505460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform.
    Gottlieb P; Utz PJ; Robinson W; Steinman L
    Clin Immunol; 2013 Dec; 149(3):297-306. PubMed ID: 24094739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen presenting cell-targeted proinsulin expression converts insulin-specific CD8
    Reeves PLS; Rudraraju R; Wong FS; Hamilton-Williams EE; Steptoe RJ
    Eur J Immunol; 2017 Sep; 47(9):1550-1561. PubMed ID: 28665492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.
    Roep BO; Solvason N; Gottlieb PA; Abreu JRF; Harrison LC; Eisenbarth GS; Yu L; Leviten M; Hagopian WA; Buse JB; von Herrath M; Quan J; King RS; Robinson WH; Utz PJ; Garren H; ; Steinman L
    Sci Transl Med; 2013 Jun; 5(191):191ra82. PubMed ID: 23803704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
    Alhadj Ali M; Liu YF; Arif S; Tatovic D; Shariff H; Gibson VB; Yusuf N; Baptista R; Eichmann M; Petrov N; Heck S; Yang JHM; Tree TIM; Pujol-Autonell I; Yeo L; Baumard L; Stenson R; Howell A; Clark A; Boult Z; Powrie J; Adams L; Wong FS; Luzio S; Dunseath G; Green K; O'Keefe A; Bayly G; Thorogood N; Andrews R; Leech N; Joseph F; Nair S; Seal S; Cheung H; Beam C; Hills R; Peakman M; Dayan CM
    Sci Transl Med; 2017 Aug; 9(402):. PubMed ID: 28794283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart.
    Schloot NC; Willemen SJ; Duinkerken G; Drijfhout JW; de Vries RR; Roep BO
    Hum Immunol; 2001 Apr; 62(4):299-309. PubMed ID: 11295462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide.
    Martinez NR; Augstein P; Moustakas AK; Papadopoulos GK; Gregori S; Adorini L; Jackson DC; Harrison LC
    J Clin Invest; 2003 May; 111(9):1365-71. PubMed ID: 12727928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma.
    Welters C; Lammoglia Cobo MF; Stein CA; Hsu MT; Ben Hamza A; Penter L; Chen X; Buccitelli C; Popp O; Mertins P; Dietze K; Bullinger L; Moosmann A; Blanc E; Beule D; Gerbitz A; Strobel J; Hackstein H; Rahn HP; Dornmair K; Blankenstein T; Hansmann L
    Cancer Immunol Res; 2022 Nov; 10(11):1407-1419. PubMed ID: 36122410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidimensional analyses of proinsulin peptide-specific regulatory T cells induced by tolerogenic dendritic cells.
    Suwandi JS; Laban S; Vass K; Joosten A; van Unen V; Lelieveldt BPF; Höllt T; Zwaginga JJ; Nikolic T; Roep BO
    J Autoimmun; 2020 Feb; 107():102361. PubMed ID: 31776056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.